Evidence map›Paper›PMID 19451396›Full record

ArticleJournal of leukocyte biology2009

Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.

Bryce N Alves, Jeff Leong, David L Tamang, Viki Elliott, Jillian Edelnant, Doug Redelman, Cherie A Singer, Andrew R Kuhn, Rita Miller, Mark E Lowe and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bryce N AlvesDepartment of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV 89557-0046, USA. brycea@gbis.com
Jeff Leong
David L Tamang
Viki Elliott
Jillian Edelnant
Doug Redelman
Cherie A Singer
Andrew R Kuhn
Rita Miller
Mark E Lowe
Dorothy Hudig
University of Nevada, Reno · USChildren's Hospital of Pittsburgh · USUniversity of Pittsburgh · US

Funding

WNT SIGNALING IN THE DEVELOPING GASTROINTESTINAL TRACTP20RR016463 · NCRR · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI WRAY, CHRISTOPHER C · 2001 to 2011
$41.0M
PANCREATIC LIPASES AND COLIPASE IN LIPOLYSIS AND OBESITYR01DK053100 · NIDDK · WASHINGTON UNIVERSITY · PI LOWE, MARK E. · 1998 to 2007
$1.7M
PROTEINASES AND LETHAL MECHANISM OF NATURAL KILLER CELLSR01CA038942 · NCI · UNIVERSITY OF NEVADA RENO · PI HUDIG, DOROTHY · 1985 to 2005
$1.3M
STRUCTURE-FUNCTION ANALYSIS OF COLIPASE AND LIPASER01HD033060 · NICHD · WASHINGTON UNIVERSITY · PI LOWE, MARK E. · 1996 to 2005
$1.0M
IDENTIFICATION AND CHARACTERIZATION OF RECEPTORS FOR GI PEPTIDESZ01DK053100 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JENSEN, ROBERT · 1990 to 2008
$724k
Intramural NIH HHS Z01 DK053100NCI NIH HHS R01 CA038942NCI NIH HHS R01CA38942-20NCRR NIH HHS P20 RR016463NCRR NIH HHS P20RR016463NICHD NIH HHS R01 HD033060NICHD NIH HHS R01HD33060NIDDK NIH HHS DK053100NIDDK NIH HHS R01 DK053100PHS HHS T32 09563
6 · The paper itself

Abstract

Pancreatic lipase-related protein 2 (PLRP2) is induced by IL-4 in vitro in cytotoxic T lymphocyte (CTL) clones and CTLs from immunized wild-type (WT) PLRP2(+/+) are more cytotoxic than PLRP2(-/-) CTLs, suggesting to previous investigators that the lipase PLRP2 might support CTL functions. Here, we further evaluate PLRP2 in CTLs. We found that PLRP2 was optimally induced in splenocytes by 3.5 x 10(-8) M IL-4 by day 6 after activation and was restricted to CD8(+) T cells. PLRP2 mRNA was detected inconsistently (and at low levels) after activation in the presence of IL-2. Cytotoxicity in 4 h (51)Cr assays of WT CTLs was approximately 3-fold the activity of PLRP2(-/-) CTLs cultured with IL-4 and, with IL-2, was unexpectedly approximately 2 fold the activity of PLRP2(-/-) CTLs. Thus, PLRP2 gene ablation affected short-term (perforin-dependent) cytotoxicity, even under the IL-2 conditions. Other variables failed to account for the reduced cytotoxicity. Granzyme B levels, activation markers, and CD8(+) T cell frequencies were similar for WT vs. PLRP2(-/-) CTLs (with either cytokine). Addition of rPLRP2 to IL-4 induced PLRP2(-/-) CTLs (or to cytotoxic granule extracts) failed to increase lysis, suggesting that the missing mediator is more than released PLRP2. Cytotoxicity of WT and PLRP2(-/-) CTLs was similar in 2-day tumor survival assays with IL-4, which can be mediated by perforin-independent mechanisms. We conclude that extracellular PLRP2 lipase is unable to directly augment the cytotoxicity that was lost by PLRP2 ablation and that after reevaluation, the question of what is PLRP2's role in CD8 T cells is still unanswered.

Indexed as

Cytotoxicity, ImmunologicAnimalsDose-Response Relationship, DrugGene ExpressionInterleukin-4LipaseMiceMice, Inbred BALB CMice, KnockoutRecombinant ProteinsT-Lymphocytes, CytotoxicInterleukin-4Lipasepancreatic lipase related protein 2Recombinant Proteins

Identifiers

PMID19451396
PMCPMC2735286
OpenAlexW2121335366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.